Related Experiment Video
Updated: Aug 15, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Abstract:
The papers reviewed in this chapter emphasise the continued difficulties in making progress with the management of advanced malignant melanoma. Data is consistently accrued to confirm the relatively favourable prognosis of thin lesions and hence the importance of early detection and educational programmes to help patients to seek medical assistance when early changes appear. The papers on regional perfusion show some encouraging results but for systemic metastases, cytotoxic drugs show very little if any true benefit. Conversely, the increased interest in biological response modifiers does hold out some genuine promise of being able to influence the course of this unpredictable and refractory malignant disease.
Related Concept Videos
Cancer
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

